Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

Title:	Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
Authors:	Budde, Lihua E.^{Aff1, IDs41591023027265_cor1}; Olszewski, Adam J.^Aff2; Assouline, Sarit^Aff3; Lossos, Izidore S.^Aff4; Diefenbach, Catherine^Aff5; Kamdar, Manali^Aff6; Ghosh, Nilanjan^Aff7; Modi, Dipenkumar^Aff8; Sabry, Waleed^Aff9; Naik, Seema^Aff10; Mehta, Amitkumar^Aff11; Nakhoda, Shazia K.^Aff12; Smith, Stephen D.^Aff13; Dorritie, Kathleen^Aff14; Jia, Ting^Aff15; Pham, Song^Aff16; Huw, Ling-Yuh^Aff17; Jing, Jing^Aff17; Wu, Hao^Aff17; Ead, Wahib S.^Aff17; To, Iris^Aff17; Batlevi, Connie Lee^Aff17; Wei, Michael C.^Aff17; Chavez, Julio C.^{Aff18, IDs41591023027265_cor24}
Source:	Nature Medicine. 30(1):229-239
Database:	Springer Nature Journals